心脏性休克中的生物标志物:老朋友,新朋友
Mathieu Jozwiak1,2, Sung Yoon Lim3,4, Xiang Si3,5
1Service de Médecine Intensive Réanimation, CHU de Nice, Hôpital L'Archet 1, 151 Route Saint Antoine de Ginestière, 06200, Nice, France. jozwiak.m@chu-nice.fr.
Annals of intensive care
|October 16, 2024
概括
生物标志物有助于诊断和监测心脏性休克,新的标如二二酶-3显示治疗潜力. 已知标记物如乳酸盐和热素具有预后价值,但缺乏对心脏性休克的特异性.
科学领域:
- 心脏病学 心脏病学
- 生物化学 生物化学
- 关键护理医学 关键护理医学
背景情况:
- 生物标志物对于管理心脏性休克,帮助诊断,治疗选择和患者监测至关重要.
- 传统的生物标志物,如乳酸,/肝功能测试和心脏托波宁,提供预后信息,但往往缺乏特异性.
- 新兴的生物标志物为心脏性休克病理生理学和潜在的治疗点提供了新的见解.
研究的目的:
- 审查各种生物标志物在心脏性休克中的作用.
- 突出既有和新生物标志物的诊断,预后和治疗潜力.
- 探索生物标志物如何为个性化治疗策略定义患者亚表型.
主要方法:
- 对心脏性休克中的生物标志物的现有文献的审查.
- 分析"旧"生物标志物的实用性 (乳酸盐,器官功能测试,心脏标志物).
- 评估较新的生物标志物,如二二酶-3和上腺素.
- 关于炎症标志物和蛋白质组分数的讨论.
- 基于生物标志物的生物"签名"的探索.
主要成果:
- 乳酸,/肝生物标志物和心脏热素具有预后价值,但在心脏性休克中具有有限的特异性.
- 滴基-3和上腺素显示出预后潜力,并可能成为未来的治疗点.
- 炎症生物标志物和蛋白质组评分越来越多地被认为具有预后意义.
- 生物标志物与临床数据相结合,可以识别出不同的患者亚表型.
结论:
- 生物标志物是对心脏性休克临床评估的重要辅助.
- 新型生物标志物,如二基酶-3和上腺素呈现有前途的治疗途径.
- 基于生物标志物驱动的患者亚型在心脏病性休克临床试验中具有准确医学的潜力.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
105
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
105
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
61
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
61
01:30Acute Coronary Syndrome III: Diagnostic studies
3
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
3
01:29Heart Failure II: Pathophysiology
3
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
3
01:24Blood Pressure Imbalances and Circulatory Shock
758
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
758
01:26Heart Failure III: Clinical Manifestations
3
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
3